Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. - Wikidata - wikimedia - TriplyDB

Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging.

Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging.

http://www.wikidata.org/entity/Q31015624

about

Colon-targeted oral drug delivery systems: design trends and approaches Translating Human Effective Jejunal Intestinal Permeability to Surface-Dependent Intrinsic Permeability: a Pragmatic Method for a More Mechanistic Prediction of Regional Oral Drug Absorption.Physiological parameters for oral delivery and in vitro testing Mammalian gastrointestinal tract parameters modulating the integrity, surface properties, and absorption of food-relevant nanomaterials Comprehensive suppression of all apoptosis-induced proliferation pathways as a proposed approach to colorectal cancer prevention and therapy Colloid formation by drugs in simulated intestinal fluid.Stimulation of colonic motility by oral PEG electrolyte bowel preparation assessed by MRI: comparison of split vs single dose.Meta-analysis of Magnetic Marker Monitoring Data to Characterize the Movement of Single Unit Dosage Forms Though the Gastrointestinal Tract Under Fed and Fasting Conditions.Taking the lead from our colleagues in medical education: the use of images of the in-vivo setting in teaching concepts of pharmaceutical science.Functional metagenomics reveals novel salt tolerance loci from the human gut microbiome Revised Estimates for the Number of Human and Bacteria Cells in the Body An oral-controlled release drug delivery system for liquid and semisolid drug formulations.Gastrointestinal pH and Transit Time Profiling in Healthy Volunteers Using the IntelliCap System Confirms Ileo-Colonic Release of ColoPulse Tablets Mathematical Models to Explore Potential Effects of Supersaturation and Precipitation on Oral Bioavailability of Poorly Soluble Drugs.Mechanistic analysis of solute transport in an in vitro physiological two-phase dissolution apparatus Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs.Predicting pharmacokinetics of drugs using physiologically based modeling--application to food effects Population-based mechanistic prediction of oral drug absorption Effect of Gastric Fluid Volume on the In Vitro Dissolution and In Vivo Absorption of BCS Class II Drugs: a Case Study with Nifedipine Colonic treatments and targets: issues and opportunities.Gastric emptying of non-disintegrating solid drug delivery systems in fasted state: relevance to drug dissolution.A biorelevant dissolution stress test device - background and experiences.New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies.Assessment of gastrointestinal motor functions by MRI: a comprehensive review.Impact of excipient interactions on drug bioavailability from solid dosage forms.Biorelevant in-vitro performance testing of orally administered dosage forms.Dissolution testing of oral modified-release dosage forms.Intestinal transporters for endogenic and pharmaceutical organic anions: the challenges of deriving in-vitro kinetic parameters for the prediction of clinically relevant drug-drug interactions.Formulation strategies to improve oral peptide delivery.Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease.A case study of in silico modelling of ciprofloxacin hydrochloride/metallic compound interactions Magnetic resonance imaging to evaluate gastrointestinal function.In Vitro and In Vivo Modeling of Hydroxypropyl Methylcellulose (HPMC) Matrix Tablet Erosion Under Fasting and Postprandial Status.Mechanistic prediction of food effects for Compound A tablet using PBPK model.An in vitro methodology for forecasting luminal concentrations and precipitation of highly permeable lipophilic weak bases in the fasted upper small intestine.Exploration of Antiemetics for Osteoporosis Therapy-Induced Nausea and Vomiting Using PET Molecular Imaging Analysis to Gastrointestinal Pharmacokinetics.A Multiparticulate Delivery System for Potential Colonic Targeting Using Bovine Serum Albumin as a Model Protein.Application of a Bayesian approach to physiological modelling of mavoglurant population pharmacokinetics.Novel orally swallowable IntelliCap(®) device to quantify regional drug absorption in human GI tract using diltiazem as model drug.

P2860

Q27002400-CA5F2B4D-1E64-4BCD-B10C-4475C2B83127 Q27313187-A18DD23F-F5F6-4C05-BFDF-A09E494F2EE2 Q27687044-78B6A201-A459-4AFD-A45C-8000AB1927C6 Q28087071-70403C38-E7FE-4E29-9CDA-66597A55C1E1 Q28542683-9C102FF9-C71A-400F-898F-F0DEE452D7A3 Q30494603-AECF30C0-5A0B-4765-A690-ADC81B9CA07C Q30838573-290F4BC2-E36E-4006-BBED-3FB929D52038 Q31020563-53665E3E-FA12-42B1-9A1A-C65C6371FC6B Q33909963-F530F356-CBB0-492F-AAD1-AF158E05299D Q34245960-B5FE4B92-2654-4D65-B463-C9EB6F55F569 Q34537872-8D176864-BFD8-48E4-956E-77BAF8F7B9F5 Q35577205-0F19204E-DCF3-482C-8429-187966013366 Q35692281-0911A14D-6FDF-4F41-9DA4-33290A9083D9 Q35768399-663EE9B0-A3C9-45DC-8318-72227250F893 Q35854694-3851A153-7D47-43F0-B9B7-8D6B7639051C Q37141404-6153771D-9A98-42C9-96F2-09A4E553C9E2 Q37149095-68F865AD-AEAA-42FA-A813-893A8BBD2BA0 Q37214520-D571637D-E253-4B2F-B4CD-C28F386A3201 Q37412091-18EE6DFB-6824-4A32-9B04-5712166AF994 Q37530912-01011631-3F6A-413F-9FA5-B20E6EE0A8AE Q37768454-30ACB669-4595-4865-A788-E3677F74A2FD Q37803213-3B4EFAF4-DC30-43E0-A836-F27A23F60606 Q37805592-C63904A5-3F4F-491A-8291-D668A6ACCE5A Q37805595-7BC4A5D5-BC35-4597-98DD-684E4CFD8C84 Q37833148-01570188-5DFA-4536-9DFE-B97F9717D113 Q38011598-3B342197-7945-4183-BBA3-890D31157173 Q38017705-2AC91559-20AB-4175-87A4-B59C627D7F55 Q38017706-5FF36E1C-76D6-4C60-822D-1AD83B850FC8 Q38051447-A30622B6-AE32-4576-9DEB-9ACAA07684BA Q38226675-324C7397-3E3E-4CC0-BBE3-1CE467CA3AE4 Q38383015-C183BD35-E37A-4BB4-8F1D-A1C8FFC60798 Q38555068-D3E8A082-868C-4B24-9979-FD19EC5ADC4A Q38644777-AF9591A3-C1E1-4518-98FE-D890164B1496 Q38762373-AACF18E2-4877-4068-B249-2D233F893EF0 Q38848902-10BE83AE-4F0B-4FA2-808D-AEF488816B2A Q39569609-0A19A332-12CD-44B7-8FD8-CEC9D22AB547 Q40003131-8A3AD233-408D-4EE3-8D8E-549221B34B63 Q40093061-CB9C5079-0C0F-460C-A753-C604863E373D Q40672523-FD5B93AB-85ED-4F39-A434-08F908D9ED50 Q41884689-200EAEFA-B79A-40D4-A974-1FB6AB8BF62C

P2860

Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging.

http://www.wikidata.org/entity/Q31015624

description

2005 nî lūn-bûn

@nan

2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Intestinal fluid volumes and t ...... by magnetic resonance imaging.

@ast

Intestinal fluid volumes and t ...... by magnetic resonance imaging.

@en

type

label

Intestinal fluid volumes and t ...... by magnetic resonance imaging.

@ast

Intestinal fluid volumes and t ...... by magnetic resonance imaging.

@en

prefLabel

Intestinal fluid volumes and t ...... by magnetic resonance imaging.

@ast

Intestinal fluid volumes and t ...... by magnetic resonance imaging.

@en

P1433

Q31015624-E84286AC-18AD-48BD-9139-7DF7E184F2B2

P1476

Q31015624-12AC6507-5CDF-47F5-AFDC-12CA13CC79A1

P2093

Q31015624-171D137C-DFFF-4416-AC79-23CDE2C574CE

Q31015624-2D52A3AE-7971-4143-9D5E-209FC779CCEA

Q31015624-58309D3E-976A-420C-8389-02828A54C24E

Q31015624-5CECE384-139E-40FE-83B9-8C8A6A13B04D

Q31015624-7FBE9A4C-01F9-43B5-BFC9-1554710FA4C5

Q31015624-8580C762-1C53-437F-95DB-38552438D873

Q31015624-95167FF1-2F38-4CFD-8D7D-A367C297ADAD

P2860

Q31015624-05A4433B-1EA2-4248-A9CF-329182B8CF1F

Q31015624-09A4B98E-A9E3-48D1-9FFE-5F2A7DD664DA

Q31015624-0AA33CCF-DF50-4ED1-A63C-376A914EF813

Q31015624-0D002862-260B-4814-85B5-2D5002256079

Q31015624-3B865509-48E4-43AC-905C-07243A5B1B37

Q31015624-6232693B-F780-4D9A-AE45-8839178F499E

Q31015624-67F7CC99-1321-4DDF-B5B6-6576AF099AF2

Q31015624-A2720657-D403-44CD-B9BB-0013718D0C0C

Q31015624-AA6ACEDC-520B-49BC-A894-E432C04BB96F

Q31015624-B49A29A1-0EF7-4AF7-9517-546476D81932

P304

Q31015624-F1264BEB-1106-4CE1-855B-D2AB139C2024

P31

Q31015624-7ABFA10F-2A7A-4E5A-8C9E-EAE2892FE621

P356

Q31015624-545B08CD-5378-4F5C-85C0-CB39CA19E66E

P407

Q31015624-C7484AC4-BADB-49A0-8457-D0C37C233676

P433

Q31015624-746A2375-F3EC-4AA7-B469-11225379E20B

P478

Q31015624-9580EBE6-AF04-4A3C-BB25-7B4C614913CC

P577

Q31015624-D23DDB56-0C68-4E3D-8B5A-087DDFC03590

P5875

Q31015624-3445061D-0F54-48B0-9D23-1120494AFD40

P698

Q31015624-AB61208F-BFC6-4BC8-891C-20E9BBA58B80

P356

J.1365-2036.2005.02683.X

P1433

Alimentary Pharmacology & Therapeutics

P1476

Intestinal fluid volumes and t ...... by magnetic resonance imaging.

@en

P2093

Fröhlich CP

http://www.w3.org/2001/XMLSchema#string

Giessmann T

http://www.w3.org/2001/XMLSchema#string

Hosten N

http://www.w3.org/2001/XMLSchema#string

Mönnikes H

http://www.w3.org/2001/XMLSchema#string

Schiller C

http://www.w3.org/2001/XMLSchema#string

Siegmund W

http://www.w3.org/2001/XMLSchema#string

Weitschies W

http://www.w3.org/2001/XMLSchema#string

P2860

Small bowel MRI using water as a contrast medium.

Gastrointestinal transit and drug absorption.

A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals.

ABC of oral bioavailability: transporters as gatekeepers in the gut.

The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability.

Aquaporins in the digestive system.

From structure to disease: the evolving tale of aquaporin biology.

Prandial and diurnal effects on the absorption of orally administered enteric coated 5-aminosalicylic acid (5-ASA).

A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibe.

In vivo evaluation of enteric-coated naproxen tablets using gamma scintigraphy.

P304

971-979

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2036.2005.02683.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7499083

http://www.w3.org/2001/XMLSchema#string

P698

16268972

http://www.w3.org/2001/XMLSchema#string